FDA approves new treatment for moderately to severely active ulcerative colitis
The U.S. Food and Drug Administration today expanded the approval of Pfizer’s Xeljanz (tofacitinib), the first oral medication approved for…
Pharmaceuticals, Biotechnology and Life Sciences
The U.S. Food and Drug Administration today expanded the approval of Pfizer’s Xeljanz (tofacitinib), the first oral medication approved for…
Hikma Pharmaceuticals said that its wholly-owned US subsidiary, West-Ward Pharmaceuticals Corp. has launched Methylergonovine Maleate Tablets, USP, 0.2mg, the generic…
Gilead Sciences has gotten the approval from the China Drug Administration (CDA) of Epclusa for the treatment of adults with…
Novartis said Tuesday that the US Food and Drug Administration (FDA) has accepted the its supplemental New Drug Application (sNDA)…
Allergan is recalling one lot of Taytulla physicians sample pack, indicated for use by women to prevent pregnancy, because of…
AstraZeneca and MedImmune, said that the trial Terranova, the second of two pivotal Phase III trials for Fasenra (benralizumab) in patients…
The U.S. Food and Drug Administration (FDA) has accepted Bayer’s partner’s Loxo Oncology’s New Drug Application (NDA), and granted Priority…
Novartis has gotten new evidence from the CHAMP-HF registry comparing Entresto patients to patients not taking Entresto, which showed that…
AstraZeneca and MedImmune, its global biologics research and development arm, on Friday reported positive overall survival (OS) results for the…
Eli Lilly said Thursday its senior vice president and president of Lilly Oncology, and the member of the company’s executive…